Neoadjuvant Endocrine Therapy in Breast Cancer Management: State of the Art

SIMPLE SUMMARY: Over the last ten years, neoadjuvant endocrine therapy (NET) has been increasingly investigated and has gained recognition. NET should not only be used to allow surgery or to improve breast-conserving surgery rates in patients not eligible for NCT, but also as a research tool for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lerebours, Florence, Cabel, Luc, Pierga, Jean-Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926493/
https://www.ncbi.nlm.nih.gov/pubmed/33670042
http://dx.doi.org/10.3390/cancers13040902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926493/
https://www.ncbi.nlm.nih.gov/pubmed/33670042
http://dx.doi.org/10.3390/cancers13040902

Ejemplares similares